Olink Holding AB (publ) Debt to Equity Ratio 2020-2024 | OLK
Current and historical debt to equity ratio values for Olink Holding AB (publ) (OLK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Olink Holding AB (publ) debt/equity for the three months ending March 31, 2024 was 0.00.
| Olink Holding AB (publ) Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.08B | $0.46B | 0.18 |
| 2023-12-31 | $0.10B | $0.50B | 0.20 |
| 2023-09-30 | $0.08B | $0.47B | 0.17 |
| 2023-06-30 | $0.06B | $0.47B | 0.13 |
| 2023-03-31 | $0.06B | $0.50B | 0.12 |
| 2022-12-31 | $0.07B | $0.41B | 0.16 |
| 2022-09-30 | $0.06B | $0.38B | 0.16 |
| 2022-06-30 | $0.06B | $0.41B | 0.15 |
| 2022-03-31 | $0.06B | $0.46B | 0.14 |
| 2021-12-31 | $0.06B | $0.48B | 0.14 |
| 2021-09-30 | $0.06B | $0.50B | 0.12 |
| 2021-06-30 | $0.06B | $0.52B | 0.11 |
| 2021-03-31 | $0.06B | $0.51B | 0.12 |
| 2020-12-31 | $0.13B | $0.30B | 0.42 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.14B | $0.21B | 0.68 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.202B | $0.170B |
| Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.257B | 19.36 |
| Tempus AI (TEM) | United States | $5.669B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
| Axonics (AXNX) | United States | $3.445B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
| Azenta (AZTA) | United States | $2.800B | 157.42 |
| Enovis (ENOV) | United States | $2.438B | 18.07 |
| 10x Genomics (TXG) | United States | $2.234B | 0.00 |
| Privia Health (PRVA) | United States | $2.022B | 113.00 |
| Schrodinger (SDGR) | United States | $1.461B | 0.00 |
| Omnicell (OMCL) | United States | $1.229B | 42.48 |
| Phreesia (PHR) | United States | $1.177B | 0.00 |
| Standard BioTools (LAB) | United States | $0.682B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| Pulmonx (LUNG) | United States | $0.245B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
| Outset Medical (OM) | United States | $0.199B | 0.00 |
| TruBridge (TBRG) | United States | $0.168B | 9.02 |
| P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.089B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.071B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| CareCloud (CCLD) | United States | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Biotricity (BTCY) | United States | $0.007B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |